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CASE REPORT
A 24-year-old man was examined at our institution 5
years ago for presumed venous insufficiency of the right
lower extremity. His symptoms included venous ulceration
of the right lower limb, which had progressed in a year. In
addition, the patient complained of disabling claudication of
the right thigh at 1 to 2 blocks. His past medical history was
significant for an episode of right popliteal venous throm-
bosis, which was treated with standard anticoagulation. This
occurred 4 years before our examination. In addition, he
also had gradual prominence of the superficial veins extend-
ing from the groin to the anterior abdominal wall. He was
initially treated with 3 months of Unna boot compression,
with no significant improvement in the stasis ulceration.
Patency of the deep system through the external iliac
veins was revealed by means of venous duplex scanning of
the right lower extremity. A stenotic segment of the right
common iliac vein was shown by means of contrast venog-
raphy. An unsuccessful attempt was made at the time of
the venogram to pass a wire through the area of stenosis
for possible angioplasty and stenting. A large collateral
venous network was seen in the vicinity of the intra-
abdominal inferior vena cava (IVC). A true IVC was not
identified. A patent IVC was seen at the level of the hepat-
ic veins, however. The right leg drained via the right inter-
nal iliac vein, with pelvic crossover to the left iliac system.
Surprisingly, mean common femoral venous pressures
were 24 mm Hg and equal on both sides, suggesting that
pelvic crossover was adequate to drain the right leg. A 13-
mm Hg mean pressure gradient was demonstrated between
the superior vena cava (SVC) and the common femoral
veins, suggesting that the drainage across the network of
caval collaterals was functionally inadequate. Laboratory
workup included normal values for complete blood cell
count, prothrombin time/partial thromboplastin time, pro-
tein C&S, antithrombin III, anticardiolipin antibody, and
lupus anticoagulant.
The patient was taken to surgery for bypass grafting of
the IVC. A right thoracoabdominal approach through the
eighth interspace was used to expose the IVC immediate-
ly above the diaphragm and at the confluence of the iliac
veins. A 16-mm ringed polytetrafluoroethylene (PTFE)
graft (Impra, Tempe, Ariz) was tunneled posterolateral to
the right kidney and posterior to the right lobe of the liver.
Anastomosis was performed end-to-side to the supra
diaphragmatic cava and end-to-side to a large pelvic col-
lateral (12 to 16 mm) immediately adjacent and in direct
continuity with the presumed confluence of the iliac veins
(Fig 1). An arteriovenous fistula was constructed in the
left groin between the superficial femoral artery and a
proximal branch of the saphenous vein (3.0 to 3.5 mm) to
augment flow through the graft. Heparin was continued
in the postoperative period, and Coumadin was initiated.
The Coumadin was continued for 3 years; then the patient
decided to stop taking the medication.
The patient’s claudication resolved postoperatively. The
venous ulceration healed with continued Unna boot therapy
within 3 weeks. Subsequently, the patient was fitted with
compression garments at 40 mm Hg counter pressure. The
arteriovenous fistula closed spontaneously 3 months postop-
eratively. Although flow was not measured through the fis-
tula when it was open, a palpable thrill was present over the
common femoral vein. A routine venogram was obtained 6
months postoperatively. The graft was patent and the stenot-
ic right common iliac vein was successfully crossed with a
wire, and underwent angioplasty and stenting (Fig 2).
Although the patient was asymptomatic, the vessel was
recannalized in an effort to improve the drainage of the right
leg. Subsequent follow-up with duplex sonography demon-
strated patency 4 years postoperatively. In addition, a mag-
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netic resonance angiogram obtained 5 years postoperatively
revealed a patent graft and patency of the iliac veins (Fig 3).
The patient remained asymptomatic.
DISCUSSION
IVC occlusion occurs infrequently. It may be
congenital or associated with perinatal thrombosis,
neoplastic invasion, trauma, and thrombosis of a
membranous web.3,4 The actual cause in this patient
remains unclear. The patient had a tortuous intra-
abdominal collateral venous network in the vicinity
of the IVC, but the true cava was not identified. This
may have been a congenital anomaly or the result of
a subhepatic occlusion very early in life. Regardless,
the collateral network of veins was hemodynamically
significant, resulting in a functional occlusion of the
IVC. We believe that the gradient of 13 mm Hg sub-
stantiates this and is the main reason that the bypass
graft remained patent. Furthermore, we believe that
bypass grafting performed in the absence of such a
gradient may be more susceptible to thrombosis.
This gradient was across the cava and not the iliac
vessels. For this reason, we started the bypass graft
from the confluence of the iliac veins and not the
right external iliac or common femoral vein. 
The patient’s venous claudication was restricted to
the right leg, despite common femoral pressures being
equal bilaterally. This could be explained by superim-
posed valvular insufficiency from the previous deep
venous thrombosis (DVT) and the possibility that
pelvic crossover may have been inadequate for ante-
grade flow during exercise. The valvular insufficiency
in the right leg may also explain the stasis dermatitis,
which was not present on the left. Although valvular
function was not specifically assessed in the duplex
studies, we presumed that the patient had valvular
incompetence as a sequela of the previous DVT. 
Prosthetic grafts, namely PTFE grafts, are becom-
ing the conduit of choice for major intra-abdominal
and pelvic venous reconstruction.5,6 Information
regarding long-term patency is limited because of the
small number of reported cases, lack of objective fol-
low-up parameters, and the large variety of venous
graft configurations and lengths. Patency for 45
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Fig 1. The guide wire is in the left common iliac vein.
Note the large amount of contrast in the tortuous venous
network in the area of the intra-abdominal inferior vena
cava. The arrow indicates a large pelvic collateral that
arose from a point in direct continuity with the presumed
confluence of the iliac veins.
Fig 2. Patent graft at 6 months with stent placement in a
stenotic segment of the right common iliac vein.
months has been documented for a long prosthetic
PTFE iliac venous reconstruction.5 Our case docu-
ments patency at 5 years and, to our knowledge, is
one of a few reported cases of long-term success for
a long caval prosthetic bypass graft.
Although few would disagree with anticoagula-
tion in the perioperative period, the question of how
long it should be continued remains unanswered.
Some believe that the thrombogenicity of the graft
is reduced with the development of a pseudoen-
dothelial lining, which occurs between 3 to 6
months, and recommend that anticoagulation be
maintained for at least this period.2,4,6 Even so, in
comparison with the arterial system, venous flow is
relatively slow, thereby resulting in a continued risk
for thrombosis. This would seem particularly true in
the case of a long prosthetic graft. It therefore
appears reasonable to maintain good-risk patients on
long-term anticoagulation, especially for long iliac
or caval grafts. Our patient stopped Coumadin at 3
years, and the graft remained patent 2 years later.
As with any other type of bypass grafting, a means
of surveillance is necessary. Duplex scanning is an
acceptable noninvasive technique of measuring graft
size and flow.7 Equivocal or abnormal scans should be
followed by contrast venography. Magnetic resonance
angiography is also a promising noninvasive approach
to the evaluation of the graft flow and patency. This
modality has been proven as a means of providing
results comparable with contrast arteriography in the
evaluation of the abdominal aorta and distal vascula-
ture.8 In the future, it may also replace contrast stud-
ies for evaluating the venous systems in a large num-
ber of patients.
In many instances, surgical revision of graft
stenoses would be technically difficult. Therefore,
percutaneous endovascular approaches that take
advantage of the relatively large diameter of the graft
(12 to 16 mm) may be a reasonable alternative.
Venous stenting techniques are evolving and, as in
this case, may offer an effective therapeutic option.9
Because long-term patency data for angioplasty and
stent placement in the venous system is not available,
close noninvasive or contrast follow-up is necessary
to detect changes that may require reintervention.
In conclusion, our case, in addition to others
reported in the literature, suggests that venous
bypass grafting in carefully selected patients pro-
duces relief of symptoms and provides acceptable
long-term patency.
REFERENCES
1. Plate G, Hollier LH, Gloviczki P, Dewanjee MK, Kaye MP.
Overcoming failure of venous vascular prostheses. Surgery
1984;96:503-9.
2. Wilson SE, Jabour A, Stone RT, Stanley TM. Patency of bio-
logic and prosthetic inferior vena cava grafts with distal limb
fistula. Arch Surg 1978;113:1174-9.
3. Victor S, Jayanthi V, Madanagopala N. Etiology of membra-
nous obstruction of the inferior vena cava. Gastroenterology
1993;104:1580-881.
4. Dougherty MJ, Calligaro KD, DeLaurentis DA. Congenitally
absent inferior vena cava presenting in adulthood with
venous stasis and ulceration: a surgically treated case. J Vasc
Surg 1996;23:141-6. 
5. Alimi YS, DiMauro P, Fabre D, Juhan C. Iliac vein recon-
structions to treat acute and chronic venous occlusive disease.
J Vasc Surg 1997;25:673-81.
6. Dale WA, Harris J, Terry RB. Polytetrafluoroethylene recon-
struction of the inferior vena cava. Surgery 1984;95:625-30.
7. Hyung J, Lee JB, Han MC, Choi BI, Im CK, Chang KH, et
al. Sonographic evaluation of the inferior vena caval obstruc-
tion: correlative study with vena cavography. Am J Roentgenol
1985;145:757-62.
8. Carpenter JP, Owen RS, Holland GA, Baum RA, Barker CF,
Perloff LJ, et al. Magnetic resonance angiography of the
aorta, iliac, and femoral arteries. Surgery 1994;116:17-23. 
9. Stone DH, Adelman MA, Rosen RJ, Riles TS, Lamparello PJ,
Jacobowitz GR, et al. A unique approach in the management
of vena caval thrombosis in a patient with Klippel-Trenaunay
syndrome. J Vasc Surg 1997;26:155-9.
Submitted May 28, 1998; accepted Aug 31, 1998.
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 4 Skinner and Ceraldi 729
Fig 3. A patent graft revealed by means of magnetic res-
onance angiography 5 years postoperatively. Although not
seen in this photograph, the iliac vessels were also patent.
